Robert LeBoyer
Stock Analyst at Noble Capital Markets
(0)
# 3194
Out of 5,269 analysts
19
Total ratings
33.33%
Success rate
3.84%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Nutriband | Initiates Coverage On: Outperform | 13 | 7.06 | 84.14% | 1 | Jan 22, 2025 | |
Geovax Labs | Maintains: Outperform | 6 10 | 1.71 | 484.8% | 2 | Aug 19, 2024 | |
Unicycive Therapeuti... | Initiates Coverage On: Outperform | 6 | 0.55 | 990.91% | 1 | Feb 14, 2024 | |
Cadrenal Therapeutic... | Initiates Coverage On: Outperform | 60 | 17.95 | 234.26% | 1 | Dec 18, 2023 | |
Eledon Pharma | Initiates Coverage On: Outperform | 10 | 4.17 | 139.81% | 1 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 14 | 1.83 | 665.03% | 1 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Sep 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 384000 | n/a | n/a | 1 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 150 | n/a | n/a | 1 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 8 | 0.54 | 1381.48% | 2 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 120 | 0.68 | 17547.06% | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 8.13 | 47.6% | 1 | Sep 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 825000 | n/a | n/a | 1 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Apr 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 4 | 275% | 2 | Mar 8, 2018 |